Coming Soon!
Contribute to groundbreaking research by joining our study on Crohn’s Disease. We aim to develop effective therapies to enhance quality of life for individuals battling this disease.
Criteria & Qualifications:
• Must be diagnosed with Crohn’s Disease.
• Aged 18 years or older.
• Willing to adhere to the trial protocol and attend all required appointments.
Compensation:
Contact us for more information
| Patient Population |
|---|
Crohn’s disease is a chronic inflammatory condition that affects the digestive tract. This clinical trial is being conducted to evaluate the efficacy and safety of guselkumab & golimumab in participants with Crohn’s disease.
Criteria & Qualifications:
• Is at least 18 years of age or older.
• Diagnosis of Crohn's disease (CD) for at least 3 months.
• Is willing to provide medical records.
Compensation:
Contact us for more information
Coming Soon!
Contribute to our research targeting Crohn's Disease within the scope of Inflammatory Bowel Disease. Your participation can lead to improved therapies and insights into this challenging condition
Criteria & Qualifications:
• Must be diagnosed with Crohn's Disease.
• Aged 18 years or older.
• Willing to participate in clinical research and follow study procedures.
Compensation:
Contact us for more information
Ulcerative Colitis causes inflammation and ulcers in the colon, resulting in abdominal discomfort. This study evaluates a new treatment's efficacy and safety for those with moderate to severe conditions. It targets individuals unsatisfied with or affected by current therapies' side effects.
Criteria & Qualifications:
• Is at least 18 years of age or older.
• Diagnosed with Ulcerative Colitis.
• Is willing to provide medical records.
Compensation:
Contact Us For More information
We invite you to participate in a study evaluating the safety and effectiveness of a new oral treatment compared to a standard control in treating and maintaining healed Erosive Esophagitis
Criteria & Qualifications:
• Is at least 18 years of age or older.
• Experience heartburn and/or regurgitation consistent with Erosive Esophagitis (EE).
Compensation: Up to $1700